Passa al contenuto
Merck
Tutte le immagini(3)

Key Documents

View All Documentation

HT90132

Sigma-Aldrich

Crystal Violet Solution

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(3)

About This Item

Formula empirica (notazione di Hill):
C25H30ClN3
Numero CAS:
548-62-9
Peso molecolare:
407.98
Beilstein:
3580948
Numero MDL:
MFCD00011750
Codice UNSPSC:
12171500
ID PubChem:
329815275
NACRES:
NA.47

Forma fisica

solution

Livello qualitativo

500

Durata

Expiry date on the label

IVD

for in vitro diagnostic use

Concentrazione

2.3%

tecniche

microbe id | staining: suitable

pH

4.6

applicazioni

hematology
histology

Temperatura di conservazione

room temp

Stringa SMILE

[Cl-].CN(C)c1ccc(cc1)\C(c2ccc(cc2)N(C)C)=C3/C=C\C(C=C3)=[N+](/C)C

InChI

1S/C25H30N3.ClH/c1-26(2)22-13-7-19(8-14-22)25(20-9-15-23(16-10-20)27(3)4)21-11-17-24(18-12-21)28(5)6;/h7-18H,1-6H3;1H/q+1;/p-1
ZXJXZNDDNMQXFV-UHFFFAOYSA-M

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Applicazioni

Intended for use in the Gram Stain Procedure No. HT90.

Componenti

Contains 2.3% certified crystal violet, 0.1% ammonium oxalate and 20% ethyl alcohol, SD3A.

Avvertenze

Warning

Indicazioni di pericolo

H226,H319,H351,H412

Classi di pericolo

Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Flam. Liq. 3

Codice della classe di stoccaggio

3 - Flammable liquids

Classe di pericolosità dell'acqua (WGK)

WGK 2

Punto d’infiammabilità (°F)

100.0 °F - closed cup

Punto d’infiammabilità (°C)

37.8 °C - closed cup

Dispositivi di protezione individuale

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 4

1 of 4

Gram’s safranin solution for microscopy

Sigma-Aldrich

94635

Gram′s safranin solution

Gentian Violet meets USP testing specifications

Sigma-Aldrich

G2039

Gentian Violet

Gentian Violet United States Pharmacopeia (USP) Reference Standard

USP

1290002

Gentian Violet

Safranin O solution

Sigma-Aldrich

HT90432

Safranin O solution

Chia-Hsun Fang et al.
Journal of biomedical science, 27(1), 42-42 (2020-03-15)
The underlying mechanism involved in ovarian cancer stemness and chemoresistance remains largely unknown. Here, we explored whether the regulation of c-Kit and plasma membrane prohibitin (PHB) affects ovarian cancer stemness and chemotherapy resistance. Mass spectrum analysis and an in vitro
Bin Xiao et al.
Cell reports, 31(4), 107571-107571 (2020-04-30)
Mechanistic target of rapamycin complex 1 (mTORC1) is a master modulator of cellular growth, and its aberrant regulation is recurrently documented within breast cancer. While the small GTPase Rheb1 is the canonical activator of mTORC1, Rheb1-independent mechanisms of mTORC1 activation
Daniel Haensel et al.
EMBO reports, 20(1) (2018-11-11)
Directional migration is inherently important for epithelial tissue regeneration and repair, but how it is precisely controlled and coordinated with cell proliferation is unclear. Here, we report that Ovol2, a transcriptional repressor that inhibits epithelial-to-mesenchymal transition (EMT), plays a crucial
Chao Wan et al.
Science advances, 6(13), eaay9789-eaay9789 (2020-04-02)
Radiotherapy (RT) is routinely used in cancer treatment, but expansion of its clinical indications remains challenging. The mechanism underlying the radiation-induced bystander effect (RIBE) is not understood and not therapeutically exploited. We suggest that the RIBE is predominantly mediated by
Niklas Gremke et al.
Nature communications, 11(1), 4684-4684 (2020-09-19)
Cancer cells have a characteristic metabolism, mostly caused by alterations in signal transduction networks rather than mutations in metabolic enzymes. For metabolic drugs to be cancer-selective, signaling alterations need to be identified that confer a druggable vulnerability. Here, we demonstrate
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.